Cholesterol and Sex Hormone Synthesis: Shared Acetyl‑CoA Pathway and Health Implications

Cholesterol and steroid hormones share a common biosynthetic origin.

Common Precursor: Acetyl‑CoA

Acetyl‑CoA (2‑carbon) from glucose (glycolysis), fatty acid β‑oxidation, or amino acid catabolism enters the mevalonate pathway in the cytosol (cholesterol) or mitochondria (steroidogenesis).

Cholesterol Synthesis (Simplified)

Acetyl‑CoA → HMG‑CoA → mevalonate → isoprenoids → squalene → lanosterol → cholesterol (27‑C). Rate‑limiting: HMG‑CoA reductase (statin target).

Steroid Hormone Synthesis

Cholesterol → (mitochondrial CYP11A1) → pregnenolone → divergent pathways:

• Adrenal cortex: Cortisol (zona fasciculata), aldosterone (zona glomerulosa), androgens (zona reticularis).
• Gonads: Testosterone (Leydig), estradiol/progesterone (theca/granulosa).
• Placenta: Progesterone, estriol.

Regulation & Clinical Correlates

• Feedback loops: HPA axis (ACTH → cortisol), HPG axis (LH/FSH → sex steroids).
• Dysregulation:
  • High cholesterol → atherosclerosis, CVD.
  • High androgens (PCOS, CAH) → hirsutism, acne, infertility.
  • Low sex steroids → osteoporosis, libido loss, metabolic syndrome.
  • Congenital enzyme deficiencies (21‑hydroxylase, 17α‑hydroxylase) → hormone imbalances.
• Shared drug targets: Statins lower cholesterol; some evidence of modest testosterone reduction. Aromatase inhibitors block estrogen synthesis (breast cancer, male infertility).

Understanding this shared pathway illuminates metabolic‑endocrine crosstalk and therapeutic opportunities.